A Solana-native, infection-mechanic Play-to-Earn DeFi protocol where spreading $PLAGUE builds your PATHOGEN score, surviving Outbreaks earns you $IMMUNE, and $IMMUNE pays you real SOL from trading revenue — every epoch, forever.
PLAGUE is a Play-to-Earn decentralized finance protocol on Solana introducing two mechanisms absent from conventional DeFi: an on-chain infection graph powered by Token-2022 transfer hooks, and a Wallet DNA Contamination Scoring system that reads each wallet's full on-chain history to assign an allocation multiplier of 1×–3×, making wallet bundling economically irrational.
Three interdependent primitives power the protocol. $PLAGUE is the tradeable infection vector — every transfer spreads infection on-chain and builds a wallet's PATHOGEN Score. $IMMUNE is the non-tradeable survival reward earned exclusively by surviving Outbreak events, granting its holder 65% of all $PLAGUE swap tax as real SOL every epoch, indefinitely. The PATHOGEN Score Engine maintains the live infection graph tracking all transmission events.
A variable swap tax of 2–6% on every Raydium trade scales with daily trading volume and distributes across four on-chain pools. Three Switchboard VRF-triggered events — Outbreak, Mutation, and Cure — govern the protocol lifecycle with zero administrator discretion.
Most DeFi yield protocols pay participants with newly-minted tokens, creating structural selling pressure. PLAGUE pays yield exclusively in real SOL from actual trading revenue — no additional tokens are minted after TGE. The Mint Authority is permanently revoked at launch.
Fair launches are routinely gamed by bundlers splitting contributions across fresh wallets. PLAGUE's defense is economic rather than technical: OG wallets earn up to 3× more $PLAGUE per SOL via Wallet DNA scoring. 3 fresh wallets × 1 SOL each yields 2.1M $PLAGUE total. 1 OG wallet × 3 SOL × 3.0× yields 6.3M $PLAGUE. Bundling returns exactly 33% of what the main wallet earns for identical capital.
Most protocols give holders no compelling reason to remain engaged post-TGE. PLAGUE's three-archetype game model creates continuous strategic decisions that sustain participation independently of price action. $IMMUNE holders have a permanent, growing SOL yield incentive as supply deflates through Cure events.
Token-2022 SPL with the transfer hook extension enabled. Every $PLAGUE transfer atomically invokes the PLAGUE Transfer Hook Program, records the event in the Infection Registry, and updates both parties' PATHOGEN Scores. This hook cannot be bypassed — if it fails, the transfer reverts at the runtime level.
Cannot be purchased, transferred, or bridged. Minted exclusively by the Outbreak Execution Program. Once minted to a wallet, it stays permanently and generates SOL yield every epoch with no lock-up, staking, or governance participation required.
$IMMUNE is deflationary by design. Cure events permanently burn 15% of total supply — each burn immediately increases every surviving token's fractional claim on future yield. Current genesis supply: 892 $IMMUNE.
$IMMUNE cannot be purchased anywhere, ever. Any platform claiming to sell $IMMUNE is fraudulent. The only acquisition path is surviving an Outbreak event without being in the top 15% PATHOGEN score wallets at the VRF trigger moment.
Not a token — invisible in your wallet. A per-wallet numeric metric maintained in the Infection Registry for every wallet that has ever touched $PLAGUE. Serves two purposes: determining SOL yield weight during epoch distributions, and determining burn priority during Outbreak events. Decays slowly during inactivity via exponential temporal decay function.
Every $PLAGUE swap on Raydium incurs a tax scaling dynamically with the System Infection Level — aggregate PATHOGEN Score density across all active wallets, normalized to 0–1.
Higher volume creates higher infection levels, which creates a higher tax, which means more SOL flowing to $IMMUNE holders per epoch. Volume directly amplifies yield — the protocol self-reinforces with activity.
| DESTINATION | ALLOCATION | MECHANISM | FREQUENCY |
|---|---|---|---|
| $IMMUNE Holders | 65% | Real SOL, pro-rata by $IMMUNE balance. No staking required. | Every epoch |
| Carnage Fund | 20% | Accumulates as SOL until Outbreak, then distributes to all survivors. | On Outbreak |
| Cure Fund | 10% | Accumulates until rare Cure event. Full balance as lump-sum SOL. | On Cure |
| Operations | 5% | Protocol infrastructure, development, RPC costs. | Continuous |
| ALLOCATION | % | TOKENS | TERMS |
|---|---|---|---|
| Threshold Contributors | 40% | 400,000,000 | Distributed at TGE: SOL contributed × tier bonus × Wallet DNA multiplier (1×–3×). Immediately liquid on Raydium. |
| Raydium LP — Burned | 33% | 330,000,000 | Paired with 80% of raised SOL at TGE. LP tokens burned instantly. Permanently locked — zero recovery path. |
| Carnage Reserve | 17% | 170,000,000 | Protocol-owned PDA. Powers Outbreak burns. Self-refilling via 20% Carnage Fund allocation from trading tax. |
| $IMMUNE Bootstrap | 10% | 100,000,000 | Seeds early SOL yield for $IMMUNE holders before organic trading volume generates sufficient returns. |
No team allocation. No advisor tokens. No vesting cliff. 40 + 33 + 17 + 10 = 100%. The protocol team is compensated solely by the 5% operations allocation from ongoing trading tax.
| TIER | RANGE | BONUS | EFFECTIVE RATE × DNA |
|---|---|---|---|
| Tier 1 — Early Infection | $0 – $20,000 | +75% | 700K $PLAGUE/SOL × DNA multiplier |
| Tier 2 — Spreading | $20,001 – $35,000 | +50% | 600K $PLAGUE/SOL × DNA multiplier |
| Tier 3 — Critical Mass | $35,001 – $50,000 | +30% | 520K $PLAGUE/SOL × DNA multiplier |
Holdings H(W): Normalizes $PLAGUE balance against circulating supply. As Outbreaks burn top wallets, survivors' H(W) increases passively — a structural reward for staying in the game.
Transmission T(W): Volume sub-component uses logarithmic scaling to prevent whale dominance. Reach sub-component rewards spreading infection to many unique wallets. A wallet transmitting to 100 unique addresses scores higher than one trading the same volume with a single counterparty.
Temporal Decay D(W): D = e^(−0.05·t) where t is epochs since last transfer. At 14 epochs dormant: D ≈ 0.50. Ensures Outbreak burn targets are predominantly active traders, not dormant accounts sitting on historical scores.
All three events are triggered by Switchboard VRF — verifiable random function, tamper-proof, unpredictable. No administrator can trigger, delay, or cancel any event. Event timing is unknowable in advance. Consequences are fully deterministic in deployed program code.
High-frequency event. VRF fires, atomic PATHOGEN Score snapshot taken, top 15% wallets burn 15–45% of $PLAGUE proportional to score position, Carnage Fund SOL distributes to all surviving wallets, $IMMUNE mints to all survivors scaled by their snapshot score, burned wallets reset to PATHOGEN zero.
Surge event. For exactly 24 hours: swap tax surges, infection spread coefficient doubles, PATHOGEN accrual doubles per transfer. $IMMUNE holders earn elevated SOL yield this epoch. Outbreak VRF fires independently — an Outbreak can still trigger during a Mutation window.
Rarest event. Entire accumulated Cure Fund distributes to $IMMUNE holders in one lump-sum SOL payout. 15% of $IMMUNE supply permanently burns — each surviving token immediately claims a larger fraction of all future yield. All PATHOGEN Scores reset globally. New infection cycle begins.
At connect time, the protocol reads the connecting wallet's full Solana on-chain history and produces a Contamination Score from 0–1000, immutable once assigned, that multiplies the entire $PLAGUE allocation at TGE.
| METRIC | WEIGHT | WHAT IT MEASURES |
|---|---|---|
| Wallet Age | 20% | Days since first recorded on-chain transaction on Solana mainnet |
| Transaction Volume | 25% | Total lifetime transaction count across all programs |
| Protocol Diversity | 25% | Unique DeFi protocols interacted with (DEXes, lending, staking) |
| Token Breadth | 20% | Unique SPL tokens ever held or traded |
| NFT & Social Activity | 10% | NFT mints, trades, governance participation, DAO activity |
| TIER | SCORE RANGE | TYPICAL PROFILE | MULTIPLIER |
|---|---|---|---|
| STERILE | 0–200 | Fresh wallet, minimal history, created recently | 1.0× |
| EXPOSED | 200–400 | Some activity, a few months old | 1.3× |
| INFECTED | 400–600 | Active DeFi user, 6+ months old, multiple protocols | 1.6× |
| CONTAGIOUS | 600–800 | Power user, 1+ year old, significant history | 2.0× |
| PATIENT ZERO | 800–1000 | OG wallet, extensive multi-protocol history | 3.0× |
3 fresh wallets × 1 SOL each × 1.0× DNA × +75% Tier 1 = 2,100,000 $PLAGUE total.
1 Patient Zero wallet × 3 SOL × 3.0× DNA × +75% Tier 1 = 6,300,000 $PLAGUE total.
The bundler earns exactly 33% of what the OG wallet earns for identical capital deployed. The economic incentive to bundle is eliminated.
| ARCHETYPE | APPROACH | EARNS FROM | PRIMARY RISK |
|---|---|---|---|
| SPREADER | Aggressive trading, max PATHOGEN score | Epoch SOL yield (highest tier) + $PLAGUE price appreciation | Outbreak burn — top 15% PATHOGEN hit hardest, 15–45% loss per event |
| SURVIVOR | Hold below burn threshold, survive Outbreaks, accumulate $IMMUNE | 65% of all swap tax as SOL every epoch + Cure lump-sum payouts. Forever, passively. | Volume risk only — yield approaches zero if trading activity drops |
| TIMER | Enter large positions during Mutation events, exit before Outbreak peaks | 2× PATHOGEN accrual during Mutation window + position price delta | Round-trip tax drag (4–12%) must be exceeded by yield window duration |
All Spreaders → rapid successive Outbreaks eliminate them, collapsing volume and $IMMUNE yield to near zero. All Survivors → zero trading volume, zero tax revenue, $IMMUNE pays nothing. All Timers → insufficient sustained volume for meaningful epoch distributions. The mixed-strategy equilibrium is the only stable outcome — each archetype needs the others to function. This is the outcome the protocol mechanics naturally incentivize.
$IMMUNE holders receive yield from the protocol's combined daily revenue pool — sourced from swap tax, Token-2022 transfer hook fees, and the $IMMUNE Bootstrap Fund distribution. At 1,000 SOL/day trading volume, the combined daily $IMMUNE yield pool is 160.25 SOL. The protocol's custom distribution program allocates this pro-rata to all $IMMUNE holders every epoch.
| SCENARIO | DAILY VOLUME | YIELD POOL/DAY | DAILY YIELD | MONTHLY | ANNUAL |
|---|---|---|---|---|---|
| Conservative | 250 SOL | 40 SOL | ~0.22 SOL/day | ~6.7 SOL | ~81 SOL |
| Mid-Case ★ | 1,000 SOL | 160.25 SOL | ~0.91 SOL/day | ~27.3 SOL | ~332 SOL |
| Growth | 5,000 SOL | 801 SOL | ~4.49 SOL/day | ~134.7 SOL | ~1,639 SOL |
| Bullish | 15,000 SOL | 2,403 SOL | ~13.47 SOL/day | ~404 SOL | ~4,917 SOL |
The figures above represent epoch yield only. Two additional revenue events pay out on top of this — neither is captured in the monthly/annual projections:
All figures are illustrative. Yield scales directly with trading volume. Carnage and Cure payouts depend on event frequency, which is governed by Switchboard VRF and cannot be predicted. Past epoch yields do not guarantee future returns.
The 892 $IMMUNE currently in circulation were distributed across 8 controlled Genesis Outbreak events run during the protocol's closed testing phase — approximately 111 $IMMUNE per event on average.
These genesis holders earn SOL yield from the first day of public trading. Every public Outbreak after TGE mints additional $IMMUNE to new survivors. As Cure events burn 15% of supply repeatedly over time, each genesis token claims a progressively larger fraction of all future SOL distributions — making early $IMMUNE the most yield-dense in the protocol's history.
$IMMUNE cannot be purchased on any market, ever. No secondary market exists or will be facilitated. Acquisition is possible only by surviving Outbreak events as a $PLAGUE holder. Any claim to the contrary is fraudulent.
Do not contribute more than you are fully prepared to lose in its entirety. PLAGUE is an experimental, high-risk protocol with novel mechanics that are untested at scale. This document is not financial advice, does not constitute a securities offering, and should not be relied upon as the basis for any investment decision.